Tokyo, Japan

Nobuyuki Ohkawa


 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Ohmiya, JP (2006)
  • Saitama, JP (2015)
  • Tokyo, JP (1993 - 2024)

Company Filing History:


Years Active: 1993-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Nobuyuki Ohkawa: Innovator in Pharmaceutical Chemistry

Introduction

Nobuyuki Ohkawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work focuses on developing compounds that have therapeutic applications, particularly in treating inflammatory and cardiovascular diseases.

Latest Patents

Ohkawa's latest patents include a urea compound that has a specific chemical structure with an activation effect on SIRT6. This compound is useful as an active component for preventing and treating inflammatory diseases. Another notable patent is for a Piperidinylpyrazolopyridine derivative, which has an excellent LCAT-activating effect. This compound serves as an active ingredient in therapeutic agents for various cardiovascular conditions, including arteriosclerosis and cerebrovascular diseases.

Career Highlights

Throughout his career, Nobuyuki Ohkawa has worked with notable companies such as Daiichi Sankyo Company, Limited and Sankyo Company, Limited. His innovative research has led to advancements in drug development and has had a positive impact on public health.

Collaborations

Ohkawa has collaborated with esteemed colleagues in his field, including Norio Nakamura and Takeshi Oshima. These partnerships have fostered a collaborative environment that enhances the quality and scope of his research.

Conclusion

Nobuyuki Ohkawa's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…